'Have discreet, separate corona and non-corona hospitals for treating these two categories of patients.' 'Concentrate on your non-corona patients as well.' 'Because then your diabetics, your hypertensives, the ones on dialysis, the asthmatics, who, if and when they get corona, are the ones who are going to require more intensive care and are going to be more at risk of death.'
Sachin Bansal, who had co-founded Flipkart with Binny Bansal in 2007, would exit the company
'Both the governments and people have to recognise that this is a long race, not a short sprint.'
'We are warning that if you get these 3.5 lakh additional non-medical people with licence, our infant mortality rate and maternal mortality rate will deteriorate'.
CAATSA was aimed at Moscow and not intended to damage the military capabilities of its 'allies and partners', US said.
Anger problems, however, don't crop up overnight. The signs are usually present at least two years before a major outburst comes to light.
Among other things, taking note of complaints against several Chinese e-commerce players such as Shein, Ali Express etc for sending shipments as 'gifts' to customers in India and avoiding duties, the government has now mandated that all e-commerce sites and apps must have a registered business entity. This will be the importer on record and subject to customs rules, report Subhayan Chakraborty, Neha Alawadhi and Karan Choudhury.
'Without it, it is going to be much, much, much, much worse.' 'In the meantime, we really need to work on a sort of war footing, given that it is a natural disaster, provide relief, provide essentials, till we get biological herd immunity, we need to get economic immunity, and also social immunity.'
A glance back at some of the important ups and down Indian Inc faced in 2018.
.jpg)
Ayurvedic expert Dr G G Gangadharan on how the ancient Indian medical practice needs to be propagated in the country of its origin
Indian economy about to take-off
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances